Showing Metabocard for uroporphyrinogen III (BASm0002575)

Common NameUroporphyrinogen iii
DescriptionUroporphyrinogens are porphyrinogen variants in which each pyrrole ring has one acetate side chain and one propionate side chain; it is formed by condensation 4 four molecules of porphobilinogen. 4 isomers are possible but only 2 commoly are found, types I and III. Uroporphyrinogen III is a functional intermediate in heme biosynthesis while Uroporphyrinogen I is produced in an abortive side reaction.
Structure
Molecular FormulaC40H44N4O16
Average Mass836.79460
Monoisotopic Mass836.27523
IUPAC Name3-[9,14,20-tris(2-carboxyethyl)-5,10,15,19-tetrakis(carboxymethyl)-21,22,23,24-tetraazapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1(20),3,5,8,10,13,15,18-octaen-4-yl]propanoic acid
Traditional NameUroporphyrinogen iii
CAS Registry Number1976-85-8
SMILESO=C([O-])CCc1c2[nH]c(c1CC(=O)[O-])Cc1[nH]c(c(CC(=O)[O-])c1CCC(=O)[O-])Cc1[nH]c(c(CC(=O)[O-])c1CCC(=O)[O-])Cc1[nH]c(c(CCC(=O)[O-])c1CC(=O)[O-])C2
InChI IdentifierInChI=1S/C40H44N4O16/c45-33(46)5-1-17-21(9-37(53)54)29-14-27-19(3-7-35(49)50)22(10-38(55)56)30(43-27)15-28-20(4-8-36(51)52)24(12-40(59)60)32(44-28)16-31-23(11-39(57)58)18(2-6-34(47)48)26(42-31)13-25(17)41-29/h41-44H,1-16H2,(H,45,46)(H,47,48)(H,49,50)(H,51,52)(H,53,54)(H,55,56)(H,57,58)(H,59,60)
InChI KeyHUHWZXWWOFSFKF-UHFFFAOYSA-N
CHEBI IDCHEBI:57308
HMDB IDHMDB0001086
Pathways
NameSMPDB/PathBank
Porphyrin Metabolism
Hereditary Coproporphyria (HCP)
Acute Intermittent Porphyria
Congenital Erythropoietic Porphyria (CEP) or Gunther Disease
Porphyria Variegata (PV)
StateSolid
Water Solubility4.37e-02 g/l
logP0.67
logS-4.28
pKa (Strongest Acidic)3.21
pKa (Strongest Basic)Not Available
Hydrogen Acceptor Count16
Hydrogen Donor Count12
Polar Surface Area361.56 Ų
Rotatable Bond Count20
Physiological Charge-8
Formal Charge0
Refractivity206.93 m³·mol⁻¹
Polarizability81.55

We require the use of cookies for essential features like storing your previously submitted BASys2 queries. Rejecting the usage of cookies will result in certain features being disabled. By clicking ACCEPT or continuing to use the website you are agreeing to our use of cookies.

ACCEPT